BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17803730)

  • 1. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog.
    Atkins CE; Rausch WP; Gardner SY; Defrancesco TC; Keene BW; Levine JF
    J Vet Pharmacol Ther; 2007 Oct; 30(5):394-400. PubMed ID: 17803730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio.
    Gardner SY; Atkins CE; Rausch WP; DeFrancesco TC; Chandler DW; Keene BW
    J Vet Cardiol; 2007 May; 9(1):1-7. PubMed ID: 17689463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC; Ames MK; Werre S; Atkins CE
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
    Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine in ambulatory hypertensive patients: humoral and haemodynamic effects.
    Letizia C; De Ciocchis A; Cerci S; Coassin S; Fisher H; Tarsitani P; Scavo D
    Int J Clin Pharmacol Res; 1993; 13(3):151-9. PubMed ID: 8225698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
    Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
    Sakatani A; Miyagawa Y; Takemura N
    J Vet Cardiol; 2016 Sep; 18(3):248-254. PubMed ID: 27364087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of amlodipine.
    Saruta T; Kanno Y; Hayashi K; Suzuki H
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S11-6. PubMed ID: 7783108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
    Konta M; Nagakawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N
    J Vet Cardiol; 2018 Oct; 20(5):376-383. PubMed ID: 30126722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
    Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
    Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension].
    Alekseenko SA; Timoshin SS; Avilova AA; Fleĭshman MIu; Lamekhova VG
    Klin Med (Mosk); 2004; 82(9):42-5. PubMed ID: 15540422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.